Navigation Links
ReSearch Pharmaceutical Services anuncia a Marc Wolff como responsable financiero
Date:7/25/2013

FORT WASHINGTON, Pennsylvania, 25 de julio de 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services, Inc. (RPS), una CRO de próxima generación que proporciona soluciones de desarrollo clínico global en fase 1-4 para las industrias de dispositivos médicos y biofarmacéutica, anunció hoy que Marc Wolff se une a la organización en el cargo de responsable financiero.

En su cargo, Marc dirigirá todas las finanzas, impuestos y aspectos de tesorería de los negocios, incluyendo las prácticas de contabilidad, presupuesto, planificación financiera, finanzas, interfaz con la comunidad financiera, análisis financiero, adquisiciones y empresas y control del rendimiento financiero, de impuestos y tesorería. Se une a la compañía procedente de Catalent Pharma Solutions, donde trabajó en un doble cargo como responsable de finanzas mundial de Softgel Technologies además de ser vicepresidente y responsable general de Softgel Businesses en Australia y Japón.

Wolff cuenta con más de 15 años de experiencia como responsable financiero en corporaciones públicas y privadas, disponiendo entre 50 millones de dólares y 1.500 millones de dólares en ingresos, con un record establecido de éxito en las principales organizaciones globales de finanzas y un valor empresariales creciente destacado. 

Acerca de RPS
ReSearch Pharmaceutical Services (RPS), el principal proveedor mundial de mercado de innovadoras soluciones de desarrollo clínico de externalización, ofrece soluciones de desarrollo clínico de fase I-IV globales completas para las industrias farmacéutica, biotecnológica, de dispositivos médicos y diagnóstico, personalizadas por tipo (grandes, tamaño medio y pequeño). Construida de forma orgánica, RPS es la organización de investigación clínica (CRO) de crecimiento más rápido dentro de las 10 primeras, y cuenta con más de 5.000 empleados y realiza operaciones en más de 64 países, disponiendo de estructuras internas propias. Estas estructuras han proporcionado a RPS y sus socios una flexibilidad de desarrollo y crecimiento superior.

Si desea más información sobre RPS, visite www.rpsweb.com.


'/>"/>
SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Water Treatment Industry Reports: Equipment Research for US & Global Wastewater Treatment Markets
2. Organovo and Methuselah Foundation Announce Funding of Bioprinting Research at Research Institutions
3. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
4. BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
5. Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) Is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research
6. ResearchMoz.us: Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
7. ResearchDx, the leading Contract Diagnostics Organization, completes their expansion into a new facility
8. Heptares Achieves First Research Milestone in Research Collaboration with Cubist
9. Leadership Through Research Collaboration Is Reflected In Articles Published In Alzheimers Association Journal
10. Todays Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn
11. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Feb. 12, 2016 On Thursday, Feb. 11, ... at St. David,s North Austin Medical Center successfully completed ... Xi ® Surgical System with Trumpf Medical,s ... Thiru Lakshman , M.D., colorectal surgeon at the ... utilizing Integrated Table Motion technology, which seamlessly combines the ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... Feb. 12 2016  OMS Supply, a large provider ... practitioners, announced today the recent launching of their new ... variety of features that enhance the user experience and ... --> --> ... new company that started in early 2016, they have ...
Breaking Medicine Technology:
(Date:2/13/2016)... Bluffton, S. C. (PRWEB) , ... February 13, 2016 , ... Hidden Cypress in Sun ... in the area of facial plastic surgery. Dr. Frederick Weniger will be hosting ... facial rejuvenation at this event, and there will be special pricing on offers. In addition, ...
(Date:2/13/2016)... ... ... Many individuals looking to lead a healthy lifestyle have decreased carbohydrate consumption and ... Fitness has delved into this niche allowing those giving up their beloved pasta a ... 30 grams of protein and only 7 grams of carbohydrates per 50 gram serving--a ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly released ... visualization technology should be used to ensure patient safety when placing an IV ... Standards mandate the use of vein visualization technology in patients with difficult venous ...
(Date:2/13/2016)... ... February 13, 2016 , ... In the early or “honeymoon” stage of ... perfection, go out of their way to be romantic, and may exaggerate a strength ... at any online dating profile. , A recent study from Queendom.com , ...
(Date:2/12/2016)... ... , ... Mystic Buddha Publishing House presents Valentine’s Day tips on different forms ... - Dr. Frederick Lenz. , According to Publisher Roger Cantu, “Blue Skies ... teaching and helping others. Valentine’s Day celebrates love in all its forms, and ...
Breaking Medicine News(10 mins):